The Lancet Rheumatology

1. Lancet Rheumatol13 Jan 2025

   Baricitinib in early polymyalgia rheumatica (BACHELOR): a randomised, double-blind, placebo-controlled, parallel-group trial

   Randomized controlled trialVasculitis & PMR

2. Lancet Rheumatol20 Dec 2024

   Sustained DMARD-free remission in subgroups of patients with rheumatoid arthritis: an analysis of two prospective cohorts with early arthritis

   Cohort studyRA

3. Lancet Rheumatol20 Dec 2024

   Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study

   Cohort studyPediatric

4. Lancet Rheumatol18 Dec 2024

   Cardiovascular events in patients with gout initiating urate-lowering therapy with or without colchicine for flare prophylaxis: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data

   Cohort studyGout & crystals

5. Lancet Rheumatol17 Dec 2024

   Allogeneic umbilical cord-derived mesenchymal stromal cells as treatment for systemic lupus erythematosus: a single-centre, open-label, dose-escalation, phase 1 study

   Cohort studyLupus & APS

6. Lancet Rheumatol5 Dec 2024

   The projected burden of arthritis among adults and children in Australia to the year 2040: a population-level forecasting study

   Research articleAcross diseases

7. Lancet Rheumatol5 Dec 2024

   Integrating evidence from lived experience of Aboriginal people and clinical practice guidelines to develop arthritis educational resources: a mixed-methods study

   Research article

8. Lancet Rheumatol22 Nov 2024

   Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial

   Randomized controlled trialLupus & APS

9. Lancet Rheumatol19 Nov 2024

   Association of historical redlining and present-day racialised economic segregation with health-care utilisation among individuals with rheumatic conditions in Massachusetts and surrounding areas of the USA: a retrospective cohort study

   Cohort studyAcross diseases

10. Lancet Rheumatol11 Nov 2024

    CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series

    Cohort studySystemic sclerosis

11. Lancet Rheumatol8 Nov 2024

    Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality among patients who are immunocompromised with COVID-19 in Hong Kong: a retrospective cohort study

    Cohort study

12. Lancet Rheumatol8 Nov 2024

    Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study

    Cohort studySystemic sclerosis

13. Lancet Rheumatol1 Nov 2024

    Patient-initiated follow-up supported by asynchronous telemedicine versus usual care in spondyloarthritis (TeleSpA-study): a randomised controlled trial of clinical and cost-effectiveness

    Randomized controlled trialSpondyloarthritis & PsA

14. Lancet Rheumatol30 Oct 2024

    Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study

    Research articleSpondyloarthritis & PsA

15. Lancet Rheumatol29 Oct 2024

    Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases framework

    Guideline or statementAutoinflammatory & rare

16. Lancet Rheumatol22 Oct 2024

    Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial

    Randomized controlled trialRA

17. Lancet Rheumatol16 Oct 2024

    Factors associated with biological and targeted synthetic disease-modifying antirheumatic drug initiation for rheumatoid arthritis in underserved patient groups in England and Wales, UK: a national cohort study

    Cohort studyRA

18. Lancet Rheumatol11 Oct 2024

    Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial

    Randomized controlled trialOsteoarthritis

19. Lancet Rheumatol18 Sep 2024

    Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study

    Cohort studyAutoinflammatory & rare

20. Lancet Rheumatol18 Sep 2024

    The effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody-associated vasculitis: a retrospective cohort study

    Cohort studyVasculitis & PMR

21. Lancet Rheumatol17 Sep 2024

    Development of rheumatoid arthritis after methotrexate in anticitrullinated protein antibody-negative people with clinically suspect arthralgia at risk of rheumatoid arthritis: 4-year data from the TREAT EARLIER trial

    Secondary analysisRA

22. Lancet Rheumatol2 Sep 2024

    Combinations of immunomodulatory agents for prevention of uveitis relapse in patients with severe Behçet's disease already on corticosteroid therapy: a randomised, open-label, head-to-head trial

    Randomized controlled trialVasculitis & PMR

23. Lancet Rheumatol28 Aug 2024

    The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study

    Cohort studySystemic sclerosis

24. Lancet Rheumatol26 Aug 2024

    Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials

    Meta-analysisLupus & APS

25. Lancet Rheumatol22 Aug 2024

    Data-driven subclassification of ANCA-associated vasculitis: model-based clustering of a federated international cohort

    Cohort studyVasculitis & PMR

26. Lancet Rheumatol22 Aug 2024

    Identification and evolution of predictors of Sjögren's disease-associated mucosa-associated lymphoid tissue lymphoma development over time: a case-control study

    Case-control studySjögren's & overlap

27. Lancet Rheumatol22 Aug 2024

    Treatment modalities of marginal zone lymphoma and overall survival, haematological response, and underlying Sjögren's disease activity: a multicentre, retrospective, observational study

    Cohort studySjögren's & overlap

28. Lancet Rheumatol14 Aug 2024

    Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis

    Meta-analysisLupus & APS

29. Lancet Rheumatol5 Aug 2024

    Use of interleukin-6 receptor antibodies in the second and third trimester of pregnancy: a retrospective cohort study

    Cohort study

30. Lancet Rheumatol24 Jul 2024

    Effectiveness of pneumococcal vaccination in adults with common immune-mediated inflammatory diseases in the UK: a case–control study

    Case-control studyAcross diseases

31. Lancet Rheumatol16 Jul 2024

    Assessing the impact of health-care access on the severity of low back pain by country: a case study within the GBD framework

    Research articleFibromyalgia & pain

32. Lancet Rheumatol9 Jul 2024

    Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

    Research articleGout & crystals

33. Lancet Rheumatol27 Jun 2024

    Annual trends in pain management modalities in patients with newly diagnosed autoimmune rheumatic diseases in the USA from 2007 to 2021: an administrative claims-based study

    Cohort studyAcross diseases

34. Lancet Rheumatol25 Jun 2024

    Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

    Randomized controlled trialSpondyloarthritis & PsA

35. Lancet Rheumatol12 Jun 2024

    Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries

    Cross-sectional studyLupus & APS

36. Lancet Rheumatol11 Jun 2024

    Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study

    Cohort studyLupus & APS

37. Lancet Rheumatol3 Jun 2024

    Outcomes after anti-tumour necrosis factor originator to biosimilar switching in children and young people with juvenile idiopathic arthritis in the UK: a national cohort study

    Cohort studyPediatric

38. Lancet RheumatolJune 2024

    Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study

    Cross-sectional studyVasculitis & PMR

39. Lancet Rheumatol30 May 2024

    Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology–European League Against Rheumatism classification criteria

    Cohort studyAutoinflammatory & rare

40. Lancet Rheumatol30 May 2024

    Supporting self-management of low back pain with an internet intervention with and without telephone support in primary care (SupportBack 2): a randomised controlled trial of clinical and cost-effectiveness

    Randomized controlled trialFibromyalgia & pain

All 184 Briefs in ExploreShowing Briefs 81–120 of 184, newest first